These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2536171)

  • 21. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.
    Landau NR; Warton M; Littman DR
    Nature; 1988 Jul; 334(6178):159-62. PubMed ID: 3260352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dextran sulfate and heparin interact with CD4 molecules to inhibit the binding of coat protein (gp120) of HIV.
    Lederman S; Gulick R; Chess L
    J Immunol; 1989 Aug; 143(4):1149-54. PubMed ID: 2545782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion.
    Clouse KA; Cosentino LM; Weih KA; Pyle SW; Robbins PB; Hochstein HD; Natarajan V; Farrar WL
    J Immunol; 1991 Nov; 147(9):2892-901. PubMed ID: 1918997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 envelope gp120 inhibits the monocyte response to chemokines through CD4 signal-dependent chemokine receptor down-regulation.
    Wang JM; Ueda H; Howard OM; Grimm MC; Chertov O; Gong X; Gong W; Resau JH; Broder CC; Evans G; Arthur LO; Ruscetti FW; Oppenheim JJ
    J Immunol; 1998 Oct; 161(8):4309-17. PubMed ID: 9780207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Envelope glycoprotein (gp120) from HIV-1 enhances Mycobacterium avium growth in human bronchoalveolar macrophages; an effect mediated by enhanced prostaglandin synthesis.
    Denis M
    Clin Exp Immunol; 1994 Oct; 98(1):123-7. PubMed ID: 7923870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+ lymphocyte function with early human immunodeficiency virus infection.
    Gurley RJ; Ikeuchi K; Byrn RA; Anderson K; Groopman JE
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1993-7. PubMed ID: 2564677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis.
    Mizukami T; Fuerst TR; Berger EA; Moss B
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9273-7. PubMed ID: 2461565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of CCR5 and CXCR4 with CD4 and gp120 in human blood monocyte-derived dendritic cells.
    Xiao X; Kinter A; Broder CC; Dimitrov DS
    Exp Mol Pathol; 2000 Jun; 68(3):133-8. PubMed ID: 10816381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide.
    Brenneman DE; Westbrook GL; Fitzgerald SP; Ennist DL; Elkins KL; Ruff MR; Pert CB
    Nature; 1988 Oct; 335(6191):639-42. PubMed ID: 2845276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.
    Berger EA; Fuerst TR; Moss B
    Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2357-61. PubMed ID: 2451247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DR is involved in the HIV-1 binding site on cells expressing MHC class II antigens.
    Mann DL; Read-Connole E; Arthur LO; Robey WG; Wernet P; Schneider EM; Blattner WA; Popovic M
    J Immunol; 1988 Aug; 141(4):1131-6. PubMed ID: 2840463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of interleukin 2 and large envelope glycoprotein (gp 120) of human immunodeficiency virus (HIV) on lymphocyte proliferative responses to cytomegalovirus.
    Krowka J; Stites D; Mills J; Hollander H; McHugh T; Busch M; Wilhelm L; Blackwood L
    Clin Exp Immunol; 1988 May; 72(2):179-85. PubMed ID: 2842093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120.
    Dianzani U; Bragardo M; Buonfiglio D; Redoglia V; Funaro A; Portoles P; Rojo J; Malavasi F; Pileri A
    Eur J Immunol; 1995 May; 25(5):1306-11. PubMed ID: 7539755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The HIV-1 surface protein gp120 has no effect on transmembrane signal transduction in T cells.
    Kaufmann R; Laroche D; Buchner K; Hucho F; Rudd C; Lindschau C; Ludwig P; Höer A; Oberdisse E; Kopp J
    J Acquir Immune Defic Syndr (1988); 1992; 5(8):760-70. PubMed ID: 1325556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: possible role of endogenous interleukin-8.
    Capobianchi MR; Barresi C; Borghi P; Gessani S; Fantuzzi L; Ameglio F; Belardelli F; Papadia S; Dianzani F
    J Virol; 1997 Feb; 71(2):1591-7. PubMed ID: 8995686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biologic activities of HIV-1 envelope glycoprotein: the effects of crosslinking.
    Cruikshank WW; Center DM; Pyle SW; Kornfeld H
    Biomed Pharmacother; 1990; 44(1):5-11. PubMed ID: 1369693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific cellular immune response and neutralizing antibodies in goats immunized with native or recombinant envelope proteins derived from human T-lymphotropic virus type IIIB and in human immunodeficiency virus-infected men.
    Krohn K; Robey WG; Putney S; Arthur L; Nara P; Fischinger P; Gallo RC; Wong-Staal F; Ranki A
    Proc Natl Acad Sci U S A; 1987 Jul; 84(14):4994-8. PubMed ID: 2440037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans.
    Pietrella D; Kozel TR; Monari C; Bistoni F; Vecchiarelli A
    J Infect Dis; 2001 Jan; 183(1):51-8. PubMed ID: 11087201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 glycoprotein gp120 disrupts CD4-p56lck/CD3-T cell receptor interactions and inhibits CD3 signaling.
    Hubert P; Bismuth G; Körner M; Debré P
    Eur J Immunol; 1995 May; 25(5):1417-25. PubMed ID: 7774645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of GP120 binding to CD4 and an assay that measures ability of sera to inhibit this binding.
    Schnittman SM; Lane HC; Roth J; Burrows A; Folks TM; Kehrl JH; Koenig S; Berman P; Fauci AS
    J Immunol; 1988 Dec; 141(12):4181-6. PubMed ID: 3264307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.